Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Sarah Cooley, MD
Fate Therapeutics
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama
Birmingham, Alabama, United States
- City of Hope
Duarte, California, United States
- University of California, San Diego (ucsd) Moores Cancer Center
San Diego, California, United States
- University of Chicago
Chicago, Illinois, United States
- Indiana Blood and Marrow Transplant
Indianapolis, Indiana, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, United States
- Weill Cornell Medicine
New York, New York, United States
- Jewish Hospital
Cincinnati, Ohio, United States
- the Ohio State University
Columbus, Ohio, United States
- Oregon Health & Science University
Portland, Oregon, United States
- Sarah Cannon Research Institute
Nashville, Tennessee, United States
- Texas Transplant Institute
San Antonio, Texas, United States
- Huntsman Cancer Institute (university of Utah)
Salt Lake City, Utah, United States
- Virginia Commonwealth University
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Dec 2016
- Primary completion
- 4 Dec 2020
- Completion
- 5 Nov 2021
- Last update posted
- 8 Feb 2023
- Registered enrollment
- 96
- Registry id
- NCT02743351
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.